DOI QR코드

DOI QR Code

Update on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand

  • Sattrachai Prasopdee (Thammasat University Research Unit in Opisthorchiasis, Cholangiocarcinoma, and Neglected Parasitic Diseases, Thammasat University) ;
  • Thittinan Rojthongpond (Chulabhorn International College of Medicine (CICM), Thammasat University) ;
  • Yanwadee Chitkoolsamphan (Chulabhorn International College of Medicine (CICM), Thammasat University) ;
  • Montinee Pholhelm (Thammasat University Research Unit in Opisthorchiasis, Cholangiocarcinoma, and Neglected Parasitic Diseases, Thammasat University) ;
  • Siraphatsorn Yusuk (Thammasat University Research Unit in Opisthorchiasis, Cholangiocarcinoma, and Neglected Parasitic Diseases, Thammasat University) ;
  • Junya Pattaraarchachai (Chulabhorn International College of Medicine (CICM), Thammasat University) ;
  • Kritiya Butthongkomvong (Medical Oncology Unit, Udonthani Cancer Hospital, Ministry of Public Health) ;
  • Jutharat Kulsantiwong (Faculty of Science, Udon Thani Rajabhat University) ;
  • Teva Phanaksri (Chulabhorn International College of Medicine (CICM), Thammasat University) ;
  • Anthicha Kunjantarachot (Chulabhorn International College of Medicine (CICM), Thammasat University) ;
  • Smarn Tesana (Thammasat University Research Unit in Opisthorchiasis, Cholangiocarcinoma, and Neglected Parasitic Diseases, Thammasat University) ;
  • Thanakrit Sathavornmanee (Chonburi Hospital, Ministry of Public Health) ;
  • Veerachai Thitapakorn (Thammasat University Research Unit in Opisthorchiasis, Cholangiocarcinoma, and Neglected Parasitic Diseases, Thammasat University)
  • Received : 2023.03.17
  • Accepted : 2023.10.02
  • Published : 2023.11.30

Abstract

This study aimed to identify the recent risk factors for Opisthorchis viverrini infection and cholangiocarcinoma (CCA) to improve disease prevention. The participants were divided into the following 3 groups based on their health status: healthy control (nonOV and nonCCA), those with O. viverrini infection (OV), and those with CCA. A questionnaire was used to explore their lifestyle and behaviors. Multivariate logistic regression and backward elimination were used to identify the significant risk factors. The results showed that the significant risk factors for both O. viverrini infection and CCA were age>50 years (odd ratio (OR)=8.44, P<0.001, 95% confidence intervals (CI) 2.98-23.90 and OR=43.47, P=0.001, 95% CI 14.71-128.45, respectively) and raw fish consumption (OR=8.48, P<0.001, 95% CI 3.18-22.63 and OR=3.15, P=0.048, 95% CI 1.01-9.86, respectively). A history of O. viverrini infection was identified as an additional risk factor for CCA (OR=20.93, P=0.011, 95% CI 2.04-215.10). This study provided an update on the risk factors for O. viverrini infection and CCA. Asymptomatic patients with O. viverrini infection, particularly those>50 years old, should be carefully monitored to prevent CCA.

Keywords

Acknowledgement

The authors thank all the patients who participated in the study and the Chulabhorn International College of Medicine (CICM) for supporting the laboratory and facilities. We would like to express our gratitude to Dr. Isara Chiawiriyabunya, who is the Director of Udonthani Cancer Hospital for the guidance and for supporting the laboratory and facilities. This study was financially supported by the Thai Government Research Fund through Thammasat University (Fund Contract No. 50/2559 and 64/2560) and was partially supported by the Thammasat University Research Unit on Opisthorchiasis, Cholangiocarcinoma, and Neglected Parasitic Diseases to V. Thitapakorn and S. Prasopdee, and the Thai Government Research Fund through Thammasat University (Fund Contract No. 36/2562) to S.Prasopdee.

References

  1. Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, et al. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop 2011;120(suppl): 158-168. https://doi.org/10.1016/j.actatropica.2010.07.006
  2. Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, et al. Cholangiocarcinoma. Nat Rev Dis Primers 2021;7(1):65. https://doi.org/10.1038/s41572-021-00300-2
  3. Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Odermatt Sinuon M, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int 2012;61(1):10-16. https://doi.org/10.1016/j.parint.2011.08.014
  4. Sripa B, Tangkawattana S, Laha T, Kaewkes S, Mallory FF, et al. Toward integrated opisthorchiasis control in northeast Thailand: the Lawa project. Acta Trop 2015;141(Pt B):361-367. https://doi.org/10.1016/j.actatropica.2014.07.017
  5. Thaewnongiew K, Singthong S, Kutchamart S, Tangsawad S, Promthet S, et al. Prevalence and risk factors for Opisthorchis viverrini infections in upper Northeast Thailand. Asian Pac J Cancer Prev 2014;15(16):6609-6612. https://doi.org/10.7314/apjcp.2014.15.16.6609
  6. Thamavit W, Bhamarapravati N, Sahaphong S, Vajrasthira S, Angsubhakorn S. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res 1978;38(12):4634-4639.
  7. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010;101(3):579-585. https://doi.org/10.1111/j.1349-7006.2009.01458.x
  8. Prasongwatana J, Laummaunwai P, Boonmars T, Pinlaor S. Viable metacercariae of Opisthorchis viverrini in northeastern Thai cyprinid fish dishes--as part of a rational program for control of O. viverrini-associated cholangiocarcinoma. Parasitol Res 2013;112(3):1323-1327. https://doi.org/10.1007/s00436-012-3154-9
  9. Sriraj P, Boonmars T, Aukkanimart R, Songsri J, Sripan P, et al. A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development. Parasitol Res 2016;115(10):3843-3852. https://doi.org/10.1007/s00436-016-5148-5
  10. Sriraj P, Aukkanimart R, Boonmars T, Wonkchalee N, Juasook A, et al. Alcohol and alkalosis enhance excystation of Opisthorchis viverrini metacercariae. Parasitol Res 2013;112(6):2397-2402. https://doi.org/10.1007/s00436-013-3346-y
  11. Pengput A, Schwartz DG. Risk factors for Opisthorchis viverrini infection: a systematic review. J Infect Public Health 2020;13(9):1265-1273. https://doi.org/10.1016/j.jiph.2020.05.028
  12. Songserm N, Promthet S, Sithithaworn P, Pientong C, Ekalaksananan T, et al. Risk factors for cholangiocarcinoma in highrisk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol 2012;36(2):89-94. https://doi.org/10.1016/j.canep.2011.11.007
  13. Jadsri S, Noojoy A. A study of liver fluke infection in Sukhothai, Thailand. Southeast Asian J Trop Med Public Health 1999;30(3):588-593.
  14. Manwong M, Songserm N, Promthet S, Matsuo K. Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study. Asian Pac J Cancer Prev 2013;14(10):5953-5956. https://doi.org/10.7314/apjcp.2013.14.10.5953
  15. Nakbun S, Thongkrajai P, Nithikathkul C. Risk factors for Opisthorchis viverrini infection in Nakhon Phanom, Thailand, where the infection is highly endemic. Asian Biomedicine 2018;12(1):45-51. https://doi.org/10.1515/abm-2018-0030
  16. Rangsin R, Mungthin M, Taamasri P, Mongklon S, Aimpun P, et al. Incidence and risk factors of Opisthorchis viverrini infections in a rural community in Thailand. Am J Trop Med Hyg 2009;81(1):152-155. https://doi.org/10.4269/ajtmh.2009.81.152
  17. Ong X, Wang YC, Sithithaworn P, Namsanor J, Taylor D, et al. Uncovering the pathogenic landscape of helminth (Opisthorchis viverrini) infections: a cross-sectional study on contributions of physical and social environment and healthcare interventions. PLoS Negl Trop Dis 2016;10(12):e0005175. https://doi.org/10.1371/journal.pntd.0005175
  18. Prakobwong S, Suwannatrai A, Sancomerang A, Chaipibool S, Siriwechtumrong N. A large scale study of the epidemiology and risk factors for the carcinogenic liver fluke Opisthorchis viverrini in Udon Thani Province, Thailand. Asian Pac J Cancer Prev 2017;18(10):2853-2860. https://doi.org/10.22034/APJCP.2017.18.10.2853